Monday, 16 January 2017

FDA to heighten DKT scrutiny following fake abortion drugs scandal



The Food and Drugs Authority (FDA) says
it will heighten surveillance of the activities
of the pharmaceutical giant, DKT
International, following revelations it
imported and distributed hundreds of
unapproved abortion pills.
Head of Drug Enforcement Department at
FDA, Thomas Amedzro, says although the
Authority will do its best to prevent a
recurrence of the incident, success will
depend on support from the public and
other stakeholders.
“When incidents of this nature occur then
we have to step up our market surveillance
effort,” he said Monday on current affairs
programme, PM Express on the Joy News
channel on Multi TV.
Joy News investigations revealed DKT
International used unregistered drugs to
terminate pregnancies at their facilities,
exposing the women to severe medical
complications.
The fake Misoprostol and Mifepristone pills
have the potential to cause severe bleeding
in women.
About 90,000 packets of the unapproved
and unlabelled drugs were brought into the
country by DKT International with the
assistance of fake drug dealers from
Nigeria and Switzerland.
A former employee of DKT International
revealed told Joy News on anonymity that
the pharmaceutical giant was distributing
and using the fake pills along with other
approved drugs.
Although the pharmaceutical giant has
been fined about GH¢50,000, there are
suggestions that it should be banned for a
few years. However, Mr Amedzro said that
is not likely to happen.
“The products will be destroyed at a cost to
[DKT]...All [DKT] activities are being
monitored,” he assured.

No comments:

Post a Comment